Enable Injections
Manufacturing · Ohio, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2863 E Sharon Rd, Cincinnati, Ohio, 4524...Phone Number
(513) 326-2800Website
www.enableinjections.comRevenue
$87 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Enable Injections
Cincinnati-based Enable Injections is a global healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of the enFuse® On-Body Delivery System. An innovative wearable technology, the enFuse system is designed to deliver large volumes of pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting superior outcomes, and advancing healthcare system economics.Explore more
Enable Injections Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enable Injections your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Enable Injections has new funding data
Earning: See what the market has to say on Enable Injections recently announced quarterly report
Click to see if Enable Injections had a recent Job posting/layoffs
Check out if Enable Injections is spiking on competitors!
Enable Injections, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Enable Injections has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Enable Injections launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Enable Injections
Recommended Actions
Find VP level buyers at Enable Injections
Find 3 more new buyers
Compare Similar Companies to Enable Injections
Compare insights from companies similar to Enable Injections, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enable Injections is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Enable Injections is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Enable Injections.
Enable Injections financials insights
Gather financial insights about Enable Injections, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$2M
2016
Multiple Rounds
$60M
2020
Debt
$2M
2022
Series C
$215M
2026
Other Financing Round
$30M
Enable Injections Tech Stack
A closer look at the technologies used by Enable Injections
Most Recent Scoops
Person-Based
Product Launch
Hiring Plans
Enable Injections has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: CAD Programs, Mechanical Engineering, Mechanical Design, Biomedical Engineering, Risk Management, and Product Design.
Hiring Plans
Hiring Plans
Enable Injections has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: SAP, and SAP Fiori. Areas of expertise include: Microsoft Visio, Discrete Manufacturing, Adhesive Bonding, Six Sigma Black Belt, Machine Assembly, Medical Device Development, and Project Proposals.
Hiring Plans
Hiring Plans
Enable Injections is hiring in Human Resources for the first time in 12 months.
Hiring Plans
Open Position
Enable Injections News & Media
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
Sarclisa SC approved in EU: first anticancer via on-body injector CirCLIQ®. Flexible home/clinic administration for multiple myeloma patients.Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi
Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across Europe Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across EuropeAptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
Digital solution will be designed to help guide users through injection process Digital solution will be designed to help guide users through injection processPress Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enable Injections
Sign Up For FreeTo access detailed company insights
Cincinnati-based Enable Injections is a global healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of the enFuse® On-Body Delivery System. An innovative wearable technology, the enFuse system is designed to deliver large volumes of pharmaceutical and biologic therapeutics v... Read More
